Brain health researchers are exploring new ways to leverage AI in the diagnosis of diseases like Alzheimer’s. One emerging field of study is that of vocal biomarkers: the way our voices sound. Some companies are even developing personal smart devices to identify vocal biomarkers — and, perhaps one day in the future, to aid in early diagnosis or even disease prevention.
We asked David Liu, the CEO of Sonde Health, to join Live Talks to explain this emerging field, and tell us a bit more about the science behind voice biomarkers and their potential for early-identification of cognitive impairment. RSVP to this live talk on Thursday, March 14th, at 10 a.m. PT/ 1 p.m. ET to learn more about vocal biomarkers and their potential for early detection of cognitive decline.
21 people are attending Sonde Health’s David Liu: Can the Sound of Your Voice Signal Cognitive Decline?